Cerebral amyloid angiopathy, APP-related
MONDO:0011583A cerebral amyloid angiopathy that has material basis in an autosomal dominant mutation of APP on chromosome 21q21.3.
Also known as: HCHWAD, amyloidosis, Cerebroarterial, APP-related, cerebral amyloid angiopathy, APP-related, cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, APP-related cerebral amyloid angiopathy, amyloidosis, hereditary, with cerebral hemorrhage, Dutch variant, cerebral amyloid angiopathy, APP-related, Arctic variant, cerebral amyloid angiopathy, APP-related, Dutch variant
194 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Heart drug tested to fight COVID-19 complications
Disease control TerminatedThis study tested a drug called CardiolRx in 90 hospitalized COVID-19 patients who also had heart disease or risk factors like diabetes or high blood pressure. The goal was to see if the drug could lower the chance of death, needing intensive care, or having heart problems. The t…
Phase: PHASE2, PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Painkiller showdown: which is safer for the heart?
Knowledge-focused TerminatedThis study looked at how two common pain relievers—celecoxib (a Coxib) and naproxen (an NSAID)—affect blood clotting in people with rheumatoid arthritis who also have heart disease or are at high risk for it. All participants took low-dose aspirin daily. The goal was to see if on…
Phase: PHASE4 • Sponsor: Platelet and Thrombosis Research, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC